$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
News
News
Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
易瑞沙的适应症有哪些呢?
2025-10-19 11:44:20
Check Details
易瑞沙目前已知获批适应症有哪些?
2025-10-19 11:44:20
Check Details
易瑞沙对肺癌有效吗?
2025-10-19 11:44:20
Check Details
易瑞沙获批的适应症有什么?
2025-10-19 11:44:20
Check Details
易瑞沙的用法和用量
2025-10-19 11:44:20
Check Details
用易瑞沙要注意什么呢?
2025-10-19 11:44:20
Check Details
易瑞沙国内售价多少呢?
2025-10-19 11:44:20
Check Details
敏感复发小细胞肺癌:卡铂联合依托泊苷可作为合理的二线化疗选择
2025-10-19 11:44:20
Check Details
中国的拉罗替尼效果怎么样
2025-10-19 11:44:20
Check Details
有哪些版本的拉罗替尼
2025-10-19 11:44:20
Check Details
维特拉克拉罗替尼与劳拉替尼哪个效果好
2025-10-19 11:44:20
Check Details
拉罗替尼多少钱
2025-10-19 11:44:20
Check Details
1
2
...
9621
9622
9623
9624
9625
9626
9627
...
10205
10206
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Enasidenib Targeted Therapy Guide: IDH2 Mutant AML Patient Medication Details
2
Anagrelide Medication Guide: Dosage, Efficacy and Side Effects Explained
3
RAS Targeted Therapy Resistance Breakthrough: mTORC1 is Key, Dalifarnib Combination Therapy Brings Hope
4
ARID1A Gene: A New Breakthrough in Tumor Immunotherapy, Turning "Cold Tumors" Hot
5
Alectinib for ALK-Positive Lung Cancer: Efficacy, Side Effects & Clinical Outlook
6
Mavacamten (Maifantuo): A Targeted Therapy for Obstructive Hypertrophic Cardiomyopathy
7
Remibrutinib (Ruipoduo): Safety, Side Effects, and Usage Guidelines
8
Which Generation TKI Is Repotrectinib? Professional Analysis of Next-Gen ROS1 Inhibitor Classification and Clinical Features
9
Brigatinib for NF2 Neurofibromatosis: Mechanism, Efficacy and Prospects
10
Dietary Guide During Goserelin Treatment: Scientific Nutrition Management to Alleviate Side Effects and Improve Quality of Life.
11
CYP26A1 Gene Emerges as New Target for Colorectal Cancer Treatment! Folate Metabolism Research Brings Hope for Immunotherapy.
12
Precision Breakthrough: Inavolisib Redefines Survival in PIK3CA-Mutant Breast Cancer